![](/img/cover-not-exists.png)
Phase I and Pharmacokinetic Study of the Oral Farnesyltransferase Inhibitor Lonafarnib Administered Twice Daily to Pediatric Patients With Advanced Central Nervous System Tumors Using a Modified Continuous Reassessment Method: A Pediatric Brain Tumor Consortium Study
Kieran, M. W., Packer, R. J., Onar, A., Blaney, S. M., Phillips, P., Pollack, I. F., Geyer, J. R., Gururangan, S., Banerjee, A., Goldman, S., Turner, C. D., Belasco, J. B., Broniscer, A., Zhu, Y., FraVolume:
25
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.09.4243
Date:
July, 2007
File:
PDF, 119 KB
english, 2007